Lipid metabolism in cancer progression and therapeutic strategies

Y Fu, T Zou, X Shen, PJ Nelson, J Li, C Wu, J Yang… - MedComm, 2021 - Wiley Online Library
Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty
acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy …

Ceramide synthase CERS4 gene downregulation is associated with KRAS mutation in colorectal cancer

T Hayama, K Hama, T Ozawa, Y Fujiwara, K Nozawa… - Scientific Reports, 2023 - nature.com
Ceramide, the central molecule in sphingolipid synthesis, is a bioactive lipid that serves as a
regulatory molecule in the anti-inflammatory responses, apoptosis, programmed necrosis …

Ceramide synthases: insights into the expression and prognosis of lung cancer

H Qian, J Deng, C Lu, G Hou, H Zhang… - Experimental Lung …, 2021 - Taylor & Francis
CerSs (ceramide synthases), a group of enzymes that catalyze the formation of ceramides
from sphingoid base and acyl-CoA substrates. As far, six types of CerSs (CerS1-CerS6) …

[HTML][HTML] High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer

S Zhang, Y Wang, L Yuan, C Hu, Z Xu… - Translational Cancer …, 2022 - ncbi.nlm.nih.gov
Background Gastric cancer is one of the most common malignant tumors worldwide.
Ceramide synthase 5 (CerS5) is a member of the CerS family. Emerging evidence has …

[HTML][HTML] C16: 0 ceramide effect on melanoma malignant behavior and glycolysis depends on its intracellular or exogenous location

R Liu, K Cao, Y Tang, J Liu, J Li, J Chen… - American Journal of …, 2020 - ncbi.nlm.nih.gov
To investigate the role of C16: 0 ceramide in melanoma metastatic behavior and glycolysis,
five common long-chain ceramides (C16: 0, C18: 0, C20: 0, C22: 0, C24: 0) were tested in …